Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesProtective actions of sex steroid hormones in Alzheimer's disease
Frontiers in Neuroendocrinology, 06/24/09
Pike CJ et al. – A review of the protective actions of sex steroid hormones in Alzheimer’s disease (AD) reports that the successful use of hormone therapies in aging men and women to delay, prevent, and or treat AD is pending research to optimize key parameters of hormone therapy and development of selective estrogen- and androgen-receptor modulators.
Methods- Review of the protective actions of sex steroid hormones in AD
- Etrogens and progestogens depletion hypothesized to increase susceptibility to AD pathogenesis -- supported by epidemiologic evidence but refuted by some clinical findings
- Experimental evidence for neuroprotective actions of estrogen for AD prevention: promotion of neuron viability and reduction of beta-amyloid accumulation
- Diminished neural responsiveness to estrogen with age and reduced neuroprotective actions of estrogen limit use of hormone therapies in aged women
- Modulation of estrogen neuroprotective actions by progestogens
- Continuous progestogen exposure associated with inhibition of estrogen actions vs cyclic delivery of progestogens that enhances estrogen neural benefits
- Normal age-related testosterone loss in men associated with increased risk for AD
- Testosterone as an endogenous neuroprotective factor increases neuronal resilience and reduces beta-amyloid accumulation
- Androgen neuroprotective effects mediated both directly by androgen pathway activation and indirectly by aromatization to estradiol and initiation of protective estrogen signaling mechanisms
Today in Dementia...keeping you current
Receive free subspecialty "5-minute updates" via email
Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy
European Journal of Neurology, 11/02/09
Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer's Disease: Systematic Review of the 'Real-World' Evidence
Dementia and Geriatric Cognitive Disorders, 11/09/09
Orthostatic Hypotension and Cognitive Function: The Atherosclerosis Risk in Communities Study
Neuroepidemiology , 11/06/09
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
The pituitary-adrenal axis in adult thalassaemic patients
European Journal of Endocrinology, 11/02/09
Outcome of gonadotropin therapy for male infertility due to hypogonadotrophic hypogonadism
Pituitary, 10/29/09
Medical treatment of Cushing's disease: Overview and recent findings
International Journal of General Medicine, 10/21/09
Sponsor
Article Search
Sponsor